FEMA5:Volunteer Assignments and Opportunities - Revision history

Jennelleh at 19:14, 10 September 2024

2024-09-10T19:14:08Z

← Older revision		Revision as of 14:14, 10 September 2024
Line 6:		Line 6:

	To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.		To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.

	__TOC__		__TOC__
	{\| class="wikitable" style="margin:auto"		{\| class="wikitable" style="margin:auto"
Line 18:		Line 19:
	!'''Notes'''		!'''Notes'''
	\|-		\|-
	\|CHAPTER 2 (TUMOURS OF THE OVARY)		\|
			==== CHAPTER 2 (TUMOURS OF THE OVARY) ====
	\|		\|
	----		----
Line 808:		Line 810:
	\|		\|
	\|-		\|-
	\|CHAPTER 3 (ENDOMETRIOSIS AND RELATED CONDITIONS)		\|
			==== CHAPTER 3 (ENDOMETRIOSIS AND RELATED CONDITIONS) ====
	\|		\|
	----		----
Line 839:		Line 842:
	\|		\|
	\|-		\|-
	\|CHAPTER 4 (TUMOURS OF THE PERITONEUM)		\|
			==== CHAPTER 4 (TUMOURS OF THE PERITONEUM) ====
	\|		\|
	----		----
Line 1,123:		Line 1,127:
	\|		\|
	\|-		\|-
	\|CHAPTER 5 (TUMOURS OF THE FALLOPIAN TUBE)		\|
			==== CHAPTER 5 (TUMOURS OF THE FALLOPIAN TUBE) ====
	\|		\|
	----		----
Line 1,297:		Line 1,302:
	\|		\|
	\|-		\|-
	\|CHAPTER 6 (TUMOURS OF THE BROAD LIGAMENT AND OTHER UTERINE LIGAMENTS)		\|
			==== CHAPTER 6 (TUMOURS OF THE BROAD LIGAMENT AND OTHER UTERINE LIGAMENTS) ====
	\|		\|
	----		----
Line 1,405:		Line 1,411:
	\|		\|
	\|-		\|-
	\|CHAPTER 7 (TUMOURS OF THE UTERINE CORPUS)		\|
			==== CHAPTER 7 (TUMOURS OF THE UTERINE CORPUS) ====
	\|		\|
	----		----
Line 1,744:		Line 1,751:
	\|		\|
	\|-		\|-
	\|CHAPTER 8 (GESTATIONAL TROPHOBLASTIC DISEASE)		\|
			==== CHAPTER 8 (GESTATIONAL TROPHOBLASTIC DISEASE) ====
	\|		\|
	----		----
Line 1,874:		Line 1,882:
	\|		\|
	\|-		\|-
	\|CHAPTER 9 (TUMOURS OF THE UTERINE CERVIX)		\|
			==== CHAPTER 9 (TUMOURS OF THE UTERINE CERVIX) ====
	\|		\|
	----		----
Line 2,235:		Line 2,244:
	\|		\|
	\|-		\|-
	\|CHAPTER 10 (TUMOURS OF THE VAGINA)		\|
			==== CHAPTER 10 (TUMOURS OF THE VAGINA) ====
	\|		\|
	----		----
Line 2,508:		Line 2,518:
	\|		\|
	\|-		\|-
	\|CHAPTER 11 (TUMOURS OF THE VULVA)		\|
			==== CHAPTER 11 (TUMOURS OF THE VULVA) ====
	\|		\|
	----		----
Line 2,737:		Line 2,748:
	\|		\|
	\|-		\|-
	\|CHAPTER 12 (NEUROENDOCRINE NEOPLASIA)		\|
			==== CHAPTER 12 (NEUROENDOCRINE NEOPLASIA) ====
	\|		\|
	----		----
Line 2,801:		Line 2,813:
	\|		\|
	\|-		\|-
	\|CHAPTER 13 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA)		\|
			==== CHAPTER 13 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA) ====
	\|		\|
	----		----
Line 2,887:		Line 2,900:
	\|		\|
	\|-		\|-
	\|CHAPTER 14 (MESENCHYMAL TUMOURS OF THE LOWER GENITAL TRACT)		\|
			==== CHAPTER 14 (MESENCHYMAL TUMOURS OF THE LOWER GENITAL TRACT) ====
	\|		\|
	----		----
Line 3,204:		Line 3,218:
	\|		\|
	\|-		\|-
	\|CHAPTER 15 (MELANOCYTIC LESIONS)		\|
			==== CHAPTER 15 (MELANOCYTIC LESIONS) ====
	\|		\|
	----		----
Line 3,290:		Line 3,305:
	\|		\|
	\|-		\|-
	\|CHAPTER 16 (METASTASIS)		\|
			==== CHAPTER 16 (METASTASIS) ====
	\|		\|
	----		----
Line 3,321:		Line 3,337:
	\|		\|
	\|-		\|-
	\|CHAPTER 17 (GENETIC TUMOUR SYNDROMES OF THE FEMALE GENITAL TRACT)		\|
			==== CHAPTER 17 (GENETIC TUMOUR SYNDROMES OF THE FEMALE GENITAL TRACT) ====
	\|		\|
	----		----

Jennelleh at 19:03, 10 September 2024

2024-09-10T19:03:59Z

← Older revision		Revision as of 14:03, 10 September 2024
Line 6:		Line 6:

	To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.		To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
			__TOC__
	{\| class="wikitable" style="margin:auto"		{\| class="wikitable" style="margin:auto"
	\|+<big>WHO Classification of Female Genital Tumours (5th Edition) Content</big>		\|+<big>WHO Classification of Female Genital Tumours (5th Edition) Content</big>

Jennelleh at 21:42, 15 July 2024

2024-07-15T21:42:11Z

← Older revision		Revision as of 16:42, 15 July 2024
Line 3,353:		Line 3,353:
	\|[[FEMA5:Lynch_syndrome\|Lynch syndrome]]		\|[[FEMA5:Lynch_syndrome\|Lynch syndrome]]
	\|Disease		\|Disease
	\|		\|[[GTS5:Volunteer Assignments and Opportunities\|See GTS5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[FEMA5:Cowden_syndrome\|Cowden syndrome]]		\|[[FEMA5:Cowden_syndrome\|Cowden syndrome]]

Jennelleh at 21:54, 12 July 2024

2024-07-12T21:54:49Z

← Older revision		Revision as of 16:54, 12 July 2024
Line 3,364:		Line 3,364:
	\|[[FEMA5:Cowden_syndrome\|Cowden syndrome]]		\|[[FEMA5:Cowden_syndrome\|Cowden syndrome]]
	\|Disease		\|Disease
	\|		\|[[DIG5:Volunteer Assignments and Opportunities\|See DIG5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[FEMA5:Li-Fraumeni_syndrome\|Li-Fraumeni syndrome]]		\|[[FEMA5:Li-Fraumeni_syndrome\|Li-Fraumeni syndrome]]

Jennelleh at 20:28, 12 July 2024

2024-07-12T20:28:14Z

← Older revision		Revision as of 15:28, 12 July 2024
Line 3,419:		Line 3,419:
	\|[[FEMA5:DICER1_syndrome_\|DICER1 syndrome]]		\|[[FEMA5:DICER1_syndrome_\|DICER1 syndrome]]
	\|Disease		\|Disease
	\|		\|[[GTS5:Volunteer Assignments and Opportunities\|See GTS5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[FEMA5:Ovarian_dysgenesis\|Ovarian dysgenesis]]		\|[[FEMA5:Ovarian_dysgenesis\|Ovarian dysgenesis]]

Jennelleh at 20:09, 12 July 2024

2024-07-12T20:09:54Z

← Older revision		Revision as of 15:09, 12 July 2024
Line 3,397:		Line 3,397:
	\|[[FEMA5:Ataxia-telangiectasia\|Ataxia-telangiectasia]]		\|[[FEMA5:Ataxia-telangiectasia\|Ataxia-telangiectasia]]
	\|Disease		\|Disease
	\|		\|[[GTS5:Volunteer Assignments and Opportunities\|See GTS5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[FEMA5:Carney_complex\|Carney complex]]		\|[[FEMA5:Carney_complex\|Carney complex]]

Jennelleh at 19:53, 12 July 2024

2024-07-12T19:53:21Z

← Older revision		Revision as of 14:53, 12 July 2024
Line 3,342:		Line 3,342:
	\|[[FEMA5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome\|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]		\|[[FEMA5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome\|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]
	\|Disease		\|Disease
	\|		\|[[GTS5:Volunteer Assignments and Opportunities\|See GTS5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[FEMA5:Lynch_syndrome\|Lynch syndrome]]		\|[[FEMA5:Lynch_syndrome\|Lynch syndrome]]

Jennelleh at 19:37, 12 July 2024

2024-07-12T19:37:00Z

← Older revision		Revision as of 14:37, 12 July 2024
Line 3,375:		Line 3,375:
	\|[[FEMA5:Li-Fraumeni_syndrome\|Li-Fraumeni syndrome]]		\|[[FEMA5:Li-Fraumeni_syndrome\|Li-Fraumeni syndrome]]
	\|Disease		\|Disease
	\|		\|[[GTS5:Volunteer Assignments and Opportunities\|See GTS5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[FEMA5:Peutz-Jeghers_syndrome\|Peutz-Jeghers syndrome]]		\|[[FEMA5:Peutz-Jeghers_syndrome\|Peutz-Jeghers syndrome]]

Jennelleh at 19:12, 12 July 2024

2024-07-12T19:12:43Z

← Older revision		Revision as of 14:12, 12 July 2024
Line 3,441:		Line 3,441:
	\|[[FEMA5:Von_Hippel-Lindau_syndrome\|Von Hippel-Lindau syndrome]]		\|[[FEMA5:Von_Hippel-Lindau_syndrome\|Von Hippel-Lindau syndrome]]
	\|Disease		\|Disease
	\|		\|[[GTS5:Volunteer Assignments and Opportunities\|See GTS5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[FEMA5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma\|Hereditary leiomyomatosis and renal cell carcinoma]]		\|[[FEMA5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma\|Hereditary leiomyomatosis and renal cell carcinoma]]

Jennelleh at 18:55, 12 July 2024

2024-07-12T18:55:47Z

← Older revision		Revision as of 13:55, 12 July 2024
Line 3,386:		Line 3,386:
	\|[[FEMA5:Peutz-Jeghers_syndrome\|Peutz-Jeghers syndrome]]		\|[[FEMA5:Peutz-Jeghers_syndrome\|Peutz-Jeghers syndrome]]
	\|Disease		\|Disease
	\|		\|[[GTS5:Volunteer Assignments and Opportunities\|See GTS5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[FEMA5:Ataxia-telangiectasia\|Ataxia-telangiectasia]]		\|[[FEMA5:Ataxia-telangiectasia\|Ataxia-telangiectasia]]